Dezocine

地佐辛

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDezocine
Drug Alias NameDalganWY-16225
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsKappa opioid receptor antagonists
TargetsMu opioid receptorKappa opioid receptor
Therapy Area/IndicationsPainPain, Postoperative
Global Approved IndicationsPainPain, Postoperative
Approved Indications in ChinaPain
Original Approved Country/TerritoryUnited States
Original Approved Date1989/12/29
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesYangtze River Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co Ltd
Inactive CompaniesAstrazeneca Limited PartnershipYangtze River Pharmaceutical (Group) Co Ltd
Active IndicationsPain
Inactive IndicationsPain, Postoperative

Other Information

ATC CodeN02AX03
Related LinksWikipediaDrugBankKEGG